IMPLANET Announces Half-Year Revenue for 2025 up 41% to €5.8 Million

About this update from Implanet Sa

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1749,"height":653,"url":"https://media.zenfs.com/en/business-wire.com/bf391d8a9725fe9373f7993b45a09921"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bsbEfDJNGP6ebaPe92dD7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM1ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bf391d8a9725fe9373f7993b45a09921","width":960,"height":358},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/dW5x5Oj4owTTi6i5QK6xnA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04OTY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/bf391d8a9725fe9373f7993b45a09921","width":1200,"height":448}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Second quarter 2025 up +71% to €3.2 millions","length":44,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Revenue in the United States increased by a factor of 5.4 in Q2 2025 and by 1.7x for the first half of 2025 compared to 2024","length":124,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Strong first half performance in medical equipment distribution, revenue quadrupled to €1.8 million","length":99,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":267,"olType":false},{"type":"text","content":"Implanet’s management will host a webinar on Tuesday, July 8, 2025 at 6:15 p.m. (CEST)","length":86,"tagName":"p","attribs":{}},{"type":"text","content":"Please register by clicking on the following link: https://app.livestorm.co/newcap-1/implanet-webinaire-de-presentation-du-chiffre-daffaires-du-1er-semestre","length":156,"tagName":"p","attribs":{}},{"type":"text","content":"BORDEAUX, France & BOSTON, July 08, 2025--(BUSINESS WIRE)--Regulatory News:","length":79,"tagName":"p"},{"type":"text","content":"IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced its revenue for the first half of 2025.","length":251,"tagName":"p"},{"type":"text","content":"Ludovic Lastennet, CEO of IMPLANET, said: "Following a second half of 2024 with strong growth of +66%, our excellent commercial performance continued into the first half of 2025, achieving growth of +41% compar...

More updates from Implanet Sa